Part 5/8:
Diving deeper into the pharmaceutical industry reveals another layer to this issue. The financial interests tied to the antidepressant market, projected to reach upwards of $26.9 billion by 2033, raise serious questions about the potential reluctance of politicians to engage in critical examinations of how these drugs influence violent behavior. With billions spent on lobbying, it's challenging to dismiss the idea that drug companies wield substantial power in dictating the end narrative amidst a shooting tragedy.